ICMR

Delhi’s Sero-Survey Finds 23.48% People Affected by COVID-19

COVID-19: ICMR Plans National Sero-Survey to Determine Population’s Exposure

There Are More Questions We Need to Ask About the COVAXIN Clinical Trials

India Has Now Conducted More Than 1 Crore COVID-19 Tests

COVID-19 Vaccine: What We Stand to Lose If ICMR Gets Its ‘Express’ Clinical Trial

Experts Say Insufficient Data Is Getting in the Way of Tackling COVID-19 in India

Some vaccines are easy to access but others require a trip to a government hospital where conditions are poor and wait times long. Credit: ps_sahana/Flickr, CC BY 2.0

India’s First COVID-19 Vaccine Gets DCGI Nod for Human Clinical Trials